CAITLIN BROOKS: Open Payments
NPI 1659701050 · CHEEKTOWAGA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 25 payments from 8 companies in 2025. Trend: 2023 $4,316 · 2024 $688 · 2025 $612
Food & beverage: $510Education: $101
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $171 |
| Teva Pharmaceuticals USA, Inc. | 5 | $156 |
| Janssen Pharmaceuticals, Inc | 2 | $75 |
| Neurocrine BioSciences, Inc. | 3 | $67 |
| Alkermes, Inc. | 2 | $48 |
| Lundbeck LLC | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: ABILIFY ASIMTUFII, INVEGA SUSTENNA, INGREZZA, REXULTI, UZEDY, ARISTADA, CAPLYTA, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
